Organogenesis Holdings (ORGO) Return on Capital Employed Growth (5y) (2022 - 2026)
Organogenesis Holdings (ORGO) Return on Capital Employed Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Organogenesis Holdings | 238.16 Mn | 191.32 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4,071.00 |
| Mar 31, 2026 | -2,321.00 |
| Dec 31, 2025 | -368.00 |
| Sep 30, 2025 | -413.00 |
| Jun 30, 2025 | 1,322.00 |
| Mar 31, 2025 | 1,476.00 |
| Dec 31, 2024 | 2,134.00 |
| Sep 30, 2024 | 2,460.00 |
| Jun 30, 2024 | 2,489.00 |
| Mar 31, 2024 | 4,047.00 |
| Dec 31, 2023 | 3,132.00 |
| Sep 30, 2023 | 2,209.00 |
| Jun 30, 2023 | 1,796.00 |
| Mar 31, 2023 | 1,491.00 |
| Dec 31, 2022 | 898.00 |
| Sep 30, 2022 | 1,049.00 |
| Jun 30, 2022 | 1,393.00 |
| Mar 31, 2022 | 1,784.00 |